Compare Axogen Inc (AXGN) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Twist Bioscience Corp — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 3× Axogen Inc's market cap. Which is the better fit depends on your goals.
| AXGN | TWST | |
|---|---|---|
Market Cap | $2.61B | $7.72B |
Sector | Technology | Health |
52-Week High | $48.48 | $124.88 |
52-Week Low | $14.16 | $24.16 |
Enterprise Value | $2.52B | $7.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
